These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 17563057)
1. Full disclosure. Angaran DM Am J Health Syst Pharm; 2007 Jun; 64(12):1331-3. PubMed ID: 17563057 [No Abstract] [Full Text] [Related]
2. Conflicts of interest. IOM panel backs public disclosure of drug company payments. Kaiser J Science; 2009 May; 324(5927):579. PubMed ID: 19407172 [No Abstract] [Full Text] [Related]
3. Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiative. Lichter AS; McKinney R JAMA; 2012 Nov; 308(20):2093-4. PubMed ID: 23188024 [No Abstract] [Full Text] [Related]
6. Conflict of Interest in Practice Guidelines Panels. Sox HC JAMA; 2017 May; 317(17):1739-1740. PubMed ID: 28464160 [No Abstract] [Full Text] [Related]
7. Conflicts of interest in medical education: recommendations from the Pew task force on medical conflicts of interest. Korn D; Carlat D JAMA; 2013 Dec; 310(22):2397-8. PubMed ID: 24327035 [No Abstract] [Full Text] [Related]
8. How do clinical practice guidelines go awry? Dachs R; Darby-Stewart A; Graber MA Am Fam Physician; 2012 Sep; 86(6):514-6. PubMed ID: 23062042 [No Abstract] [Full Text] [Related]
9. [Politics for conflicts of interest]. Chabot JM Rev Prat; 2009 Nov; 59(9):1279-80. PubMed ID: 19961087 [No Abstract] [Full Text] [Related]
10. Controlling conflict of interest--proposals from the Institute of Medicine. Steinbrook R N Engl J Med; 2009 May; 360(21):2160-3. PubMed ID: 19403898 [No Abstract] [Full Text] [Related]
11. Can the Institute of Medicine review the FDA? Carroll BJ Nat Med; 2005 Apr; 11(4):369. PubMed ID: 15812509 [No Abstract] [Full Text] [Related]
12. CAM shock and awe. Hammerly M Health Forum J; 2003; 46(3):42. PubMed ID: 12942769 [No Abstract] [Full Text] [Related]
13. Under the influence? IOM conflict-of-interest report raises concerns. Rhea S Mod Healthc; 2009 May; 39(18):8-9. PubMed ID: 19472501 [No Abstract] [Full Text] [Related]
14. Relieving pain in America: insights from an Institute of Medicine committee. Dzau VJ; Pizzo PA JAMA; 2014 Oct; 312(15):1507-8. PubMed ID: 25321905 [No Abstract] [Full Text] [Related]
15. Reply to "Can the Institute of Medicine review the FDA?". Fineberg HV Nat Med; 2005 Jun; 11(6):589. PubMed ID: 15937463 [No Abstract] [Full Text] [Related]
16. Pragmatic and proportional analysis of conflict of interest. Bean S Am J Bioeth; 2011 Jan; 11(1):39-40. PubMed ID: 21240808 [No Abstract] [Full Text] [Related]
17. IOM warns about physician-pharma conflicts of interest. Landers SJ; O'Reilly KB Del Med J; 2009 Jul; 81(7):261-3. PubMed ID: 19902777 [No Abstract] [Full Text] [Related]
18. The IOM-CAM roller coaster. Hammerly M Altern Ther Health Med; 2003; 9(4):16. PubMed ID: 12868247 [No Abstract] [Full Text] [Related]
19. Congress responds to the IOM drug safety report--in full. Psaty BM; Korn D JAMA; 2007 Nov; 298(18):2185-7. PubMed ID: 18000202 [No Abstract] [Full Text] [Related]
20. Improving QIOs. Control of regulatory role at center of debate. DoBias M Mod Healthc; 2006 Mar; 36(11):8-9. PubMed ID: 16579106 [No Abstract] [Full Text] [Related] [Next] [New Search]